Preclinical and First-in-Human Evidence Supporting 4-Hydroxybenzoic Acid as a Treatment for COQ2-associated Mitochondrial Disease - Distelmaier, F.; Corral-Sarasa, J.; Jiménez-Sánchez, L.; Díaz-Casado, M. E.; Rohmann, M.; Seibt, A.; Herebian, D.; Smits, S.; Münch, J.; Mayatepek, E.; Breitkreutz, J.; Husain, R.; López-Herrador, S.; González-García, P.; López, L. (Neuropediatrics, 2025)